Does UNSPECIFIED INGREDIENT Cause Second primary malignancy? 29 Reports in FDA Database
Grow Your Own Natural Pharmacy at Home
Medicinal Garden Kit — 10 healing herbs, 4,818 seeds + step-by-step guide.
According to the FDA Adverse Event Reporting System (FAERS), 29 reports of Second primary malignancy have been filed in association with UNSPECIFIED INGREDIENT. This represents 0.1% of all adverse event reports for UNSPECIFIED INGREDIENT.
29
Reports of Second primary malignancy with UNSPECIFIED INGREDIENT
0.1%
of all UNSPECIFIED INGREDIENT reports
6
Deaths
10
Hospitalizations
How Dangerous Is Second primary malignancy From UNSPECIFIED INGREDIENT?
Of the 29 reports, 6 (20.7%) resulted in death, 10 (34.5%) required hospitalization.
Is Second primary malignancy Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for UNSPECIFIED INGREDIENT. However, 29 reports have been filed with the FAERS database.
What Other Side Effects Does UNSPECIFIED INGREDIENT Cause?
Death (2,090)
Off label use (1,306)
Drug ineffective (1,227)
Completed suicide (1,190)
Nausea (1,041)
Fatigue (1,020)
Dyspnoea (934)
Pneumonia (903)
Asthenia (894)
Vomiting (877)
What Other Drugs Cause Second primary malignancy?
CYCLOPHOSPHAMIDE (1,247)
DOXORUBICIN (1,151)
VINCRISTINE (908)
IMATINIB (763)
PALBOCICLIB (658)
RITUXIMAB (646)
RUXOLITINIB (611)
ETOPOSIDE (573)
PREDNISONE (517)
OCTREOTIDE (496)
Which UNSPECIFIED INGREDIENT Alternatives Have Lower Second primary malignancy Risk?
UNSPECIFIED INGREDIENT vs UPADACITINIB
UNSPECIFIED INGREDIENT vs URAPIDIL
UNSPECIFIED INGREDIENT vs UREA
UNSPECIFIED INGREDIENT vs URIDINE TRIACETATE
UNSPECIFIED INGREDIENT vs UROFOLLITROPIN